COVID-19 trials registries data warehouse

 Return to trial list

Trial - IRCT20171219037964N3


Column Value
Trial registration number IRCT20171219037964N3
Full text link
Last imported at : Dec. 3, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

First author
Last imported at : Dec. 3, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Shaghayegh haghjooy Javanmard

Contact
Last imported at : Dec. 3, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

research@mui.ac.ir

Registration date
Last imported at : Dec. 3, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2020-12-02

Recruitment status
Last imported at : Jan. 19, 2021, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Completed

Study design
Last imported at : Dec. 3, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

RCT

Allocation
Last imported at : Dec. 3, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Randomized

Design
Last imported at : Dec. 3, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Parallel

Masking
Last imported at : Dec. 3, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Blind label

Center
Last imported at : Dec. 3, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

multi-center

Study aim
Last imported at : Dec. 3, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Treatment

Inclusion criteria
Last imported at : Dec. 3, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

definite case of Covid-19 age over 18 presented within 5 days from the start of sign and symptoms

Exclusion criteria
Last imported at : Dec. 3, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

severe cases with SpO2 under 90 using an antiviral in previous two weeks previous infection with covid-19 using an steroid in previous two weeks being under treatment with steroid previous allergic to Favipiravir renal failure hepatic failure pregnancy lactating

Number of arms
Last imported at : Dec. 3, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

2

Funding
Last imported at : Dec. 3, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Esfahan University of Medical Sciences

Inclusion age min
Last imported at : Dec. 3, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

18

Inclusion age max
Last imported at : Dec. 3, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

100

Countries
Last imported at : Dec. 3, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Iran

Type of patients
Last imported at : Dec. 3, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Mild disease at enrollment

Severity scale
Last imported at : Dec. 3, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

1: Mild disease at enrollment

Total sample size
Last imported at : Dec. 3, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

70

primary outcome
Last imported at : Dec. 3, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

treatment failure side effects

Notes
Last imported at : Dec. 3, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase
Last imported at : Dec. 3, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

Phase 3

Arms
Last imported at : Dec. 3, 2020, 1 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)

[{"arm_notes": "", "treatment_id": 504, "treatment_name": "Favipiravir", "treatment_type": "Antivirals", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]